Cargando…
Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history – an open-label randomised trial (the EPPI trial): study protocol
BACKGROUND: Preeclampsia and intrauterine fetal growth restriction (IUGR) are two of the most common causes of maternal and perinatal morbidity and mortality. Current methods of predicting those at most risk of these conditions remain relatively poor, and in clinical practice past obstetric history...
Autores principales: | Groom, K. M., McCowan, L. M., Stone, P. R., Chamley, L. C., McLintock, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120461/ https://www.ncbi.nlm.nih.gov/pubmed/27876004 http://dx.doi.org/10.1186/s12884-016-1162-y |
Ejemplares similares
-
Academic contributions to the development of evidence and policy systems: an EPPI Centre collective autoethnography
por: Oliver, Sandy, et al.
Publicado: (2023) -
Machine learning for screening prioritization in systematic reviews: comparative performance of Abstrackr and EPPI-Reviewer
por: Tsou, Amy Y., et al.
Publicado: (2020) -
Elevated Liver Enzymes in Cases of Preeclampsia and Intrauterine Growth Restriction
por: Dacaj, Ramadan, et al.
Publicado: (2016) -
Melatonin, a Potential Therapeutic Agent for Preeclampsia, Reduces the Extrusion of Toxic Extracellular Vesicles from Preeclamptic Placentae
por: Tang, Yunhui, et al.
Publicado: (2021) -
Early Onset Preeclampsia and Intrauterine Growth Restriction: A Case Report
por: Almuhaytib, Fahimah A, et al.
Publicado: (2023)